Genetic Analysis of Indel Markers in Three Loci Associated with Parkinson's Disease

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2017 Sep 6

PMID 28873462

Citations 6

Authors

Zhixin Huo

Xiaoguang Luo

Xiaoni Zhan

Qiaohong Chu

Qin Xu

Jun Yao

Hao Pang

Affiliations

Soon will be listed here.

Abstract

The causal mutations and genetic polymorphisms associated with susceptibility to Parkinson's disease (PD) have been extensively described. To explore the potential contribution of insertion (I)/deletion (D) polymorphisms (indels) to the risk of PD in a Chinese population, we performed genetic analyses of indel loci in ACE, DJ-1, and GIGYF2 genes. Genomic DNA was extracted from venous blood of 348 PD patients and 325 age- and sex-matched controls without neurodegenerative disease. Genotyping of the indel loci was performed by fragment length analysis after PCR and DNA sequencing. Our results showed a statistically significant association for both allele X (alleles without 5) vs. 5 (odds ratio = 1.378, 95% confidence interval = 1.112-1.708, P = 0.003) and genotype 5/X+X/X vs. 5/5 (odds ratio = 1.681, 95% confidence interval = 1.174-2.407, P = 0.004) in the GIGYF2 locus; however, no significant differences were detected for the ACE and DJ-1 indels. After stratification by gender, no significant differences were observed in any indels. These results indicate that the GIGYF2 indel may be associated with increased risk of PD in northern China.

Citing Articles

Tool evaluation for the detection of variably sized indels from next generation whole genome and targeted sequencing data.

Wang N, Lysenkov V, Orte K, Kairisto V, Aakko J, Khan S PLoS Comput Biol. 2022; 18(2):e1009269.

PMID: 35176018 PMC: 8916674. DOI: 10.1371/journal.pcbi.1009269.

Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson's disease.

Pierzchlinska A, Slawek J, Mak M, Gawronska-Szklarz B, Bialecka M Mol Biol Rep. 2021; 48(7):5541-5548.

PMID: 34302265 PMC: 8301732. DOI: 10.1007/s11033-021-06569-6.

Association Analyses of , and Single-Nucleotide Polymorphisms with Parkinson's Disease in a Northern Chinese Population.

Dai C, Zhang Y, Zhan X, Tian M, Pang H Neuropsychiatr Dis Treat. 2021; 17:1689-1695.

PMID: 34079266 PMC: 8166815. DOI: 10.2147/NDT.S304062.

Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease.

Saini P, Rudakou U, Yu E, Ruskey J, Asayesh F, Laurent S Neurobiol Aging. 2020; 100:119.e7-119.e13.

PMID: 33239198 PMC: 7940813. DOI: 10.1016/j.neurobiolaging.2020.10.019.

Association between a polymorphism and the risk of Parkinson's disease: a PRISMA-compliant systematic review and meta-analysis.

Liu J, Li C, Zhou X, Sun J, Zhu M, Zhang H J Int Med Res. 2020; 48(8):300060520947943.

PMID: 32814486 PMC: 7444142. DOI: 10.1177/0300060520947943.

References

Pankratz N, Nichols W, Uniacke S, Halter C, Rudolph A, Shults C . Significant linkage of Parkinson disease to chromosome 2q36-37. Am J Hum Genet. 2003; 72(4):1053-7. PMC: 1180337. DOI: 10.1086/374383. View

Giovannone B, Lee E, Laviola L, Giorgino F, Cleveland K, Smith R . Two novel proteins that are linked to insulin-like growth factor (IGF-I) receptors by the Grb10 adapter and modulate IGF-I signaling. J Biol Chem. 2003; 278(34):31564-73. DOI: 10.1074/jbc.M211572200. View

Guella I, Pistocchi A, Asselta R, Rimoldi V, Ghilardi A, Sironi F . Mutational screening and zebrafish functional analysis of GIGYF2 as a Parkinson-disease gene. Neurobiol Aging. 2010; 32(11):1994-2005. DOI: 10.1016/j.neurobiolaging.2009.12.016. View

Cao L, Zhang T, Zheng L, Wang Y, Wang G, Zhang J . The GIGYF2 variants are not associated with Parkinson's disease in the mainland Chinese population. Parkinsonism Relat Disord. 2010; 16(4):294-7. DOI: 10.1016/j.parkreldis.2009.11.009. View

Zhu X, Bouzekri N, Southam L, Cooper R, Adeyemo A, McKenzie C . Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet. 2001; 68(5):1139-48. PMC: 1226095. DOI: 10.1086/320104. View

Liu R, Zhou L, Cheng X, Sun M, Hu Y, Chen S . CCDC62 variant rs12817488 is associated with the risk of Parkinson's disease in a Han Chinese population. Eur Neurol. 2013; 71(1-2):77-83. DOI: 10.1159/000354333. View

Kehoe P, Russ C, McIlory S, Williams H, Holmans P, Holmes C . Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat Genet. 1999; 21(1):71-2. DOI: 10.1038/5009. View

Fahn S . Description of Parkinson's disease as a clinical syndrome. Ann N Y Acad Sci. 2003; 991:1-14. DOI: 10.1111/j.1749-6632.2003.tb07458.x. View

Bonifati V, Rizzu P, van Baren M, Schaap O, Breedveld G, Krieger E . Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. 2002; 299(5604):256-9. DOI: 10.1126/science.1077209. View

10.

Sadhukhan T, Biswas A, Das S, Ray K, Ray J . DJ-1 variants in Indian Parkinson's disease patients. Dis Markers. 2012; 33(3):127-35. PMC: 3810687. DOI: 10.1155/2012/467085. View

11.

Li L, Funayama M, Tomiyama H, Li Y, Yoshino H, Sasaki R . No evidence for pathogenic role of GIGYF2 mutation in Parkinson disease in Japanese patients. Neurosci Lett. 2010; 479(3):245-8. DOI: 10.1016/j.neulet.2010.05.071. View

12.

Firouzabadi N, Ghazanfari N, Shoushtari A, Erfani N, Fathi F, Bazrafkan M . Genetic Variants of Angiotensin-Converting Enzyme Are Linked to Autism: A Case-Control Study. PLoS One. 2016; 11(4):e0153667. PMC: 4833406. DOI: 10.1371/journal.pone.0153667. View

13.

Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F . An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990; 86(4):1343-6. PMC: 296868. DOI: 10.1172/JCI114844. View

14.

Papapetropoulos S, Glynos K, Zhou Z, Orfanos S, Mitsi G, Papapetropoulos A . The insertion/deletion polymorphism of the angiotensin converting enzyme (ACE) in Parkinson's disease. Open Neurol J. 2009; 2:66-70. PMC: 2627518. DOI: 10.2174/1874205X00802010066. View

15.

Rozenkrantz L, Gan-Or Z, Gana-Weisz M, Mirelman A, Giladi N, Bar-Shira A . SEPT14 Is Associated with a Reduced Risk for Parkinson's Disease and Expressed in Human Brain. J Mol Neurosci. 2016; 59(3):343-50. DOI: 10.1007/s12031-016-0738-3. View

16.

Kraus-Perrotta C, Lagalwar S . Expansion, mosaicism and interruption: mechanisms of the CAG repeat mutation in spinocerebellar ataxia type 1. Cerebellum Ataxias. 2016; 3:20. PMC: 5118900. DOI: 10.1186/s40673-016-0058-y. View

17.

Verma D, Chakraborti B, Karmakar A, Bandyopadhyay T, Singh A, Sinha S . Sexual dimorphic effect in the genetic association of monoamine oxidase A (MAOA) markers with autism spectrum disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 50:11-20. DOI: 10.1016/j.pnpbp.2013.11.010. View

18.

Lieb K, Treffurth Y, Berger M, Fiebich B . Substance P and affective disorders: new treatment opportunities by neurokinin 1 receptor antagonists?. Neuropsychobiology. 2002; 45 Suppl 1:2-6. DOI: 10.1159/000049254. View

19.

Yu R, Guo J, Wang Y, Liu Z, Sun Z, Su L . The single nucleotide polymorphism Rs12817488 is associated with Parkinson's disease in the Chinese population. J Clin Neurosci. 2015; 22(6):1002-4. DOI: 10.1016/j.jocn.2014.11.024. View

20.

Glanzmann B, Lombard D, Carr J, Bardien S . Screening of two indel polymorphisms in the 5'UTR of the DJ-1 gene in South African Parkinson's disease patients. J Neural Transm (Vienna). 2013; 121(2):135-8. DOI: 10.1007/s00702-013-1094-x. View